Experimental Therapeutics Targeting Aberrant Alternative Splicing of Androgen Receptor Gene Expression in Castration Resistant Prostate Cancer

StatusFinished
Effective start/end date1/01/1531/12/15

Funding

  • UTSW Center for Translational Medicine: $24,780.00

Keywords

  • Biotechnology & Drug Development, Cancer Research